Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3777345019 | Product containing dapagliflozin and metformin and saxagliptin (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3777346018 | Dapagliflozin- and metformin- and saxagliptin-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4612941000052119 | läkemedel som innehåller dapagliflozin, metformin och saxagliptin | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing dapagliflozin and metformin and saxagliptin (medicinal product) | Is a | Product containing dapagliflozin (medicinal product) | true | Inferred relationship | Some | ||
| Product containing dapagliflozin and metformin and saxagliptin (medicinal product) | Has active ingredient | Metformin (substance) | true | Inferred relationship | Some | 1 | |
| Product containing dapagliflozin and metformin and saxagliptin (medicinal product) | Has active ingredient | Saxagliptin (substance) | true | Inferred relationship | Some | 2 | |
| Product containing dapagliflozin and metformin and saxagliptin (medicinal product) | Has active ingredient | Dapagliflozin (substance) | true | Inferred relationship | Some | 3 | |
| Product containing dapagliflozin and metformin and saxagliptin (medicinal product) | Plays role | Antidiabetic therapeutic role (role) | true | Inferred relationship | Some | ||
| Product containing dapagliflozin and metformin and saxagliptin (medicinal product) | Is a | Medicinal product acting as antidiabetic agent (product) | true | Inferred relationship | Some | ||
| Product containing dapagliflozin and metformin and saxagliptin (medicinal product) | Is a | Product containing metformin and saxagliptin (medicinal product) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only dapagliflozin and metformin and saxagliptin (medicinal product) | Is a | True | Product containing dapagliflozin and metformin and saxagliptin (medicinal product) | Inferred relationship | Some | |
| Dapagliflozin- and metformin- and saxagliptin-containing product in oral dose form | Is a | True | Product containing dapagliflozin and metformin and saxagliptin (medicinal product) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR